Regulatory press release12/16/2025, 7:57 AMChordate Medical terminates the liquidity guarantee for the common share
Regulatory press release12/8/2025, 3:30 PMBulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Regulatory press release11/18/2025, 6:40 PMNotice to the Extraordinary General Meeting in Chordate Medical Holding AB (publ)
Regulatory press release11/18/2025, 6:30 PMThe board of directors of Chordate proposes that the general meeting resolves on voluntary liquidation and delisting
Regulatory press release8/21/2025, 6:30 AMChordate Announces Cost Reduction and Focus on Company Sale
Press release8/19/2025, 6:30 AMChordate reports preliminary conclusions from long-term study on chronic migraine: PM010
Regulatory press release7/17/2025, 1:45 PMBulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Regulatory press release6/30/2025, 4:45 PMNotice of Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Regulatory press release6/30/2025, 4:30 PMChordate decides on a conditional directed new issue of Preference Shares of approximately SEK 2.55 million
Press release6/27/2025, 6:30 AMChordate presents conclusions from the second data monitoring of the ongoing open-label long-term study on chronic migraine: PM010
Regulatory press release5/23/2025, 6:30 AMChordate Medical Holding AB (publ) Interim Report January-March 2025
Regulatory press release5/21/2025, 2:15 PMCommuniqué from the Annual General Meeting of Chordate Medical Holding AB (publ)
Press release5/20/2025, 9:00 AMBioStock: BioStock: New distributor strengthens Chordate Medical’s investment in Saudi Arabia
Press release5/13/2025, 8:45 AMChordate Medical Expands Migraine Offering in Saudi Arabia – Appoints Additional Distributor
Regulatory press release5/7/2025, 8:55 AMChordate Medical terminates the liquidity provider agreement for the preference share